3 articles tagged with #pharma-ai. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
Nvidia has invested in Generate Biomedicines, a biotech company leveraging AI for drug discovery in a market valued at $1.8 trillion. The investment demonstrates AI's expanding applications beyond traditional tech sectors and signals growing capital allocation toward AI-driven healthcare innovation.
Researchers propose SciDC, a method that constrains large language model outputs using subject-specific scientific rules to reduce hallucinations and improve reliability. The approach demonstrates 12% average accuracy improvements across domain tasks including drug formulation, clinical diagnosis, and chemical synthesis planning.
Sanofi is developing proprietary AI tools and workflows instead of purchasing off-the-shelf agentic AI products from SaaS vendors, positioning itself to gain competitive advantages in pharmaceutical development. This strategic shift reflects growing pharmaceutical interest in building custom AI capabilities tailored to specific industry needs rather than relying on generic enterprise solutions.
